Trial Profile
Atorva-af prevention study.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 May 2017
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atrial fibrillation; Ischaemic heart disorders
- Focus Therapeutic Use
- 06 Oct 2009 New trial record